APO RESEARCH · REPORT
Ursodeoxycholic Acid
Ursodeoxycholic Acid is also known as ursodiol (USAN). Ursodeoxycholic acid (3α, 7β-2-hydroxy-5β-bile acid, UDCA) was first found in the bile of a black bear. Ursodeoxycholic Acid is an important clinical drug in the treatment of gallstones, cholecystitis, PBC, and PSC and has broad market prospects. In previous work, ursodeoxycholic acid was prepared by traditional organic synthesis. In this report, the Ursodeoxycholic Acid we mentioned is Ursodeoxycholic Acid. And the CAS number is 128-13-2.
Product & engineering
Understand the product.
Ursodeoxycholic Acid is also known as ursodiol (USAN). Ursodeoxycholic acid (3α, 7β-2-hydroxy-5β-bile acid, UDCA) was first found in the bile of a black bear. Ursodeoxycholic Acid is an important clinical drug in the treatment of gallstones, cholecystitis, PBC, and PSC and has broad market prospects. In previous work, ursodeoxycholic acid was prepared by traditional organic synthesis. In this report, the Ursodeoxycholic Acid we mentioned is Ursodeoxycholic Acid. And the CAS number is 128-13-2.
Selected research
Industry Research
Ursodeoxycholic Acid Industry Research Report 2026
Market perspective
Ursodeoxycholic Acid is also known as ursodiol (USAN). Ursodeoxycholic acid (3α, 7β-2-hydroxy-5β-bile acid, UDCA) was first found in the bile of a black bear. Ursodeoxycholic Acid is an important clinical drug in the treatment of gallstones, cholecystitis, PBC, and PSC and has broad market prospects. In previous work, ursodeoxycholic acid was prepared by traditional organic synthesis. In this report, the Ursodeoxycholic Acid we mentioned is Ursodeoxycholic Acid. And the CAS number is 128-13-2.
Global Ursodeoxycholic Acid key players include ICE, Mitsubishi Tanabe Pharma, Daewoong Chemical, PharmaZell GmbH, Dipharma Francis, etc. Global top five manufacturers hold a share about 65%. Asia-Pacific is the largest market, with a share about 50%, followed by Europe, with a share about 30 percent. In terms of product, Synthetic UDCA is the largest segment, with a share about 95%. And in terms of application, the largest application is Pharmacy, followed by Health Products.
Report Scope
Read the full market overview
This report quantifies the global Ursodeoxycholic Acid market in terms of revenue (US$ million) and, where applicable, sales volume (MT), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/MT) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Ursodeoxycholic Acid Market by Company
ICE
Mitsubishi Tanabe Pharma
Daewoong Chemical
PharmaZell GmbH
Zhongshan belling
Dipharma Francis
Grindeks
Erregierre
Abil Chempharma
Biotavia Labs
Suzhou Tianlu
Arcelor Chemicals
Ursodeoxycholic Acid Segment by Type
Synthetic UDCA
Extraction UDCA
Ursodeoxycholic Acid Segment by Application
Pharmacy
Health Products
Ursodeoxycholic Acid Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ursodeoxycholic Acid market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ursodeoxycholic Acid and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ursodeoxycholic Acid.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Ursodeoxycholic Acid manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Ursodeoxycholic Acid by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Ursodeoxycholic Acid in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Synthetic UDCA
- Extraction UDCA
Applications
- Pharmacy
- Health Products
Companies covered
- ICE
- Mitsubishi Tanabe Pharma
- Daewoong Chemical
- PharmaZell GmbH
- Zhongshan belling
- Dipharma Francis
- Grindeks
- Erregierre
- Abil Chempharma
- Biotavia Labs
- Suzhou Tianlu
- Arcelor Chemicals
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Ursodeoxycholic Acid Market Size (2021-2032)
- 2.2.2 Global Ursodeoxycholic Acid Sales (2021-2032)
- 2.2.3 Global Ursodeoxycholic Acid Market Average Price (2021-2032)
- 2.3 Ursodeoxycholic Acid by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Synthetic UDCA
- 2.3.3 Extraction UDCA
- 2.4 Ursodeoxycholic Acid by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Pharmacy
- 2.4.3 Health Products
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Ursodeoxycholic Acid Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Ursodeoxycholic Acid Sales (MT) of Manufacturers (2021-2026)
- 3.3 Global Ursodeoxycholic Acid Revenue of Manufacturers (2021-2026)
- 3.4 Global Ursodeoxycholic Acid Average Price by Manufacturers (2021-2026)
- 3.5 Global Ursodeoxycholic Acid Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Ursodeoxycholic Acid, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Ursodeoxycholic Acid, Product Type & Application
- 3.8 Global Manufacturers of Ursodeoxycholic Acid, Established Date
- 3.9 Global Ursodeoxycholic Acid Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 ICE
- 4.1.1 ICE Company Information
- 4.1.2 ICE Business Overview
- 4.1.3 ICE Ursodeoxycholic Acid Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 ICE Ursodeoxycholic Acid Product Portfolio
- 4.1.5 ICE Recent Developments
- 4.2 Mitsubishi Tanabe Pharma
- 4.2.1 Mitsubishi Tanabe Pharma Company Information
- 4.2.2 Mitsubishi Tanabe Pharma Business Overview
- 4.2.3 Mitsubishi Tanabe Pharma Ursodeoxycholic Acid Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Mitsubishi Tanabe Pharma Ursodeoxycholic Acid Product Portfolio
- 4.2.5 Mitsubishi Tanabe Pharma Recent Developments
- 4.3 Daewoong Chemical
- 4.3.1 Daewoong Chemical Company Information
- 4.3.2 Daewoong Chemical Business Overview
- 4.3.3 Daewoong Chemical Ursodeoxycholic Acid Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Daewoong Chemical Ursodeoxycholic Acid Product Portfolio
- 4.3.5 Daewoong Chemical Recent Developments
- 4.4 PharmaZell GmbH
- 4.4.1 PharmaZell GmbH Company Information
- 4.4.2 PharmaZell GmbH Business Overview
- 4.4.3 PharmaZell GmbH Ursodeoxycholic Acid Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 PharmaZell GmbH Ursodeoxycholic Acid Product Portfolio
- 4.4.5 PharmaZell GmbH Recent Developments
- 4.5 Zhongshan belling
- 4.5.1 Zhongshan belling Company Information
- 4.5.2 Zhongshan belling Business Overview
- 4.5.3 Zhongshan belling Ursodeoxycholic Acid Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Zhongshan belling Ursodeoxycholic Acid Product Portfolio
- 4.5.5 Zhongshan belling Recent Developments
- 4.6 Dipharma Francis
- 4.6.1 Dipharma Francis Company Information
- 4.6.2 Dipharma Francis Business Overview
- 4.6.3 Dipharma Francis Ursodeoxycholic Acid Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Dipharma Francis Ursodeoxycholic Acid Product Portfolio
- 4.6.5 Dipharma Francis Recent Developments
- 4.7 Grindeks
- 4.7.1 Grindeks Company Information
- 4.7.2 Grindeks Business Overview
- 4.7.3 Grindeks Ursodeoxycholic Acid Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Grindeks Ursodeoxycholic Acid Product Portfolio
- 4.7.5 Grindeks Recent Developments
- 4.8 Erregierre
- 4.8.1 Erregierre Company Information
- 4.8.2 Erregierre Business Overview
- 4.8.3 Erregierre Ursodeoxycholic Acid Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Erregierre Ursodeoxycholic Acid Product Portfolio
- 4.8.5 Erregierre Recent Developments
- 4.9 Abil Chempharma
- 4.9.1 Abil Chempharma Company Information
- 4.9.2 Abil Chempharma Business Overview
- 4.9.3 Abil Chempharma Ursodeoxycholic Acid Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Abil Chempharma Ursodeoxycholic Acid Product Portfolio
- 4.9.5 Abil Chempharma Recent Developments
- 4.10 Biotavia Labs
- 4.10.1 Biotavia Labs Company Information
- 4.10.2 Biotavia Labs Business Overview
- 4.10.3 Biotavia Labs Ursodeoxycholic Acid Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Biotavia Labs Ursodeoxycholic Acid Product Portfolio
- 4.10.5 Biotavia Labs Recent Developments
- 4.11 Suzhou Tianlu
- 4.11.1 Suzhou Tianlu Company Information
- 4.11.2 Suzhou Tianlu Business Overview
- 4.11.3 Suzhou Tianlu Ursodeoxycholic Acid Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Suzhou Tianlu Ursodeoxycholic Acid Product Portfolio
- 4.11.5 Suzhou Tianlu Recent Developments
- 4.12 Arcelor Chemicals
- 4.12.1 Arcelor Chemicals Company Information
- 4.12.2 Arcelor Chemicals Business Overview
- 4.12.3 Arcelor Chemicals Ursodeoxycholic Acid Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Arcelor Chemicals Ursodeoxycholic Acid Product Portfolio
- 4.12.5 Arcelor Chemicals Recent Developments
5 Global Ursodeoxycholic Acid Market Scenario by Region
- 5.1 Global Ursodeoxycholic Acid Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Ursodeoxycholic Acid Sales by Region: 2021-2032
- 5.2.1 Global Ursodeoxycholic Acid Sales by Region: 2021-2026
- 5.2.2 Global Ursodeoxycholic Acid Sales by Region: 2027-2032
- 5.3 Global Ursodeoxycholic Acid Revenue by Region: 2021-2032
- 5.3.1 Global Ursodeoxycholic Acid Revenue by Region: 2021-2026
- 5.3.2 Global Ursodeoxycholic Acid Revenue by Region: 2027-2032
- 5.4 North America Ursodeoxycholic Acid Market Facts & Figures by Country
- 5.4.1 North America Ursodeoxycholic Acid Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Ursodeoxycholic Acid Sales by Country (2021-2032)
- 5.4.3 North America Ursodeoxycholic Acid Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Ursodeoxycholic Acid Market Facts & Figures by Country
- 5.5.1 Europe Ursodeoxycholic Acid Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Ursodeoxycholic Acid Sales by Country (2021-2032)
- 5.5.3 Europe Ursodeoxycholic Acid Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Ursodeoxycholic Acid Market Facts & Figures by Country
- 5.6.1 Asia Pacific Ursodeoxycholic Acid Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Ursodeoxycholic Acid Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Ursodeoxycholic Acid Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Ursodeoxycholic Acid Market Facts & Figures by Country
- 5.7.1 South America Ursodeoxycholic Acid Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Ursodeoxycholic Acid Sales by Country (2021-2032)
- 5.7.3 South America Ursodeoxycholic Acid Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Ursodeoxycholic Acid Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Ursodeoxycholic Acid Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Ursodeoxycholic Acid Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Ursodeoxycholic Acid Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Ursodeoxycholic Acid Sales by Type (2021-2032)
- 6.1.1 Global Ursodeoxycholic Acid Sales by Type (2021-2032) & (MT)
- 6.1.2 Global Ursodeoxycholic Acid Sales Market Share by Type (2021-2032)
- 6.2 Global Ursodeoxycholic Acid Revenue by Type (2021-2032)
- 6.2.1 Global Ursodeoxycholic Acid Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Ursodeoxycholic Acid Revenue Market Share by Type (2021-2032)
- 6.3 Global Ursodeoxycholic Acid Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Ursodeoxycholic Acid Sales by Application (2021-2032)
- 7.1.1 Global Ursodeoxycholic Acid Sales by Application (2021-2032) & (MT)
- 7.1.2 Global Ursodeoxycholic Acid Sales Market Share by Application (2021-2032)
- 7.2 Global Ursodeoxycholic Acid Revenue by Application (2021-2032)
- 7.2.1 Global Ursodeoxycholic Acid Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Ursodeoxycholic Acid Revenue Market Share by Application (2021-2032)
- 7.3 Global Ursodeoxycholic Acid Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Ursodeoxycholic Acid Value Chain Analysis
- 8.1.1 Ursodeoxycholic Acid Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Ursodeoxycholic Acid Production Mode & Process
- 8.2 Ursodeoxycholic Acid Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Ursodeoxycholic Acid Distributors
- 8.2.3 Ursodeoxycholic Acid Customers
9 Global Ursodeoxycholic Acid Analyzing Market Dynamics
- 9.1 Ursodeoxycholic Acid Industry Trends
- 9.2 Ursodeoxycholic Acid Industry Drivers
- 9.3 Ursodeoxycholic Acid Industry Opportunities and Challenges
- 9.4 Ursodeoxycholic Acid Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst